Correlation Between Regeneron Pharmaceuticals and VHAI

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and VHAI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and VHAI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and VHAI, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and VHAI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of VHAI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and VHAI.

Diversification Opportunities for Regeneron Pharmaceuticals and VHAI

0.57

Correlation Coefficient

Regeneron Pharmaceuticals  VHAI

Very weak diversification

The 3 months correlation between Regeneron and VHAI is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and VHAI in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VHAI and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with VHAI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VHAI has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and VHAI go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and VHAI

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.23 times more return on investment than VHAI. However, Regeneron Pharmaceuticals is 4.34 times less risky than VHAI. It trades about -0.39 of its potential returns per unit of risk. VHAI is currently generating about -0.15 per unit of risk. If you would invest  92,279  in Regeneron Pharmaceuticals on August 31, 2024 and sell it today you would lose (16,792) from holding Regeneron Pharmaceuticals or give up 18.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  VHAI

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

VHAI

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VHAI has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Regeneron Pharmaceuticals and VHAI

The main advantage of trading using opposite Regeneron Pharmaceuticals and VHAI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, VHAI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VHAI will offset losses from the drop in VHAI's long position.

The idea behind Regeneron Pharmaceuticals and VHAI pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.